THE finance director of British Biotech has resigned from drug development group with immediate effect and is leaving the company, it was announced yesterday. Chief executive Dr Keith McCullagh said a search had already begun for a suitable successor to Mr James Noble who has been finance director at the Oxford-based group since the end of 1990. Mr Noble said he had achieved his principal ambitions at the company.